# Sources — Friedrich Nietzsche

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 5, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Stanford Encyclopedia of Philosophy. “Friedrich Nietzsche” (substantive revision June 25, 2026). Born October 15, 1844, in Röcken near Leipzig, where his father was a Lutheran minister; his father died in 1849; chair of classical philology at Basel in May 1869; leave in 1876–77 and resignation by 1879; winters near the Mediterranean and summers in Sils Maria; “intense headaches, nausea, and trouble with his eyesight” and the recent argument for a retro-orbital meningioma; the collapse in Turin in January 1889, dementia, and care by his mother and later his sister; death in 1900 “of a stroke complicated by pneumonia”; his sister's editing of the notebooks as *The Will to Power*, “not well founded in Nietzsche's surviving plans” and “marred by Elisabeth's strong anti-Semitic commitments.” https://plato.stanford.edu/entries/nietzsche/
2. Klassik Stiftung Weimar. “Nietzsche-Archiv.” The archive founded in Naumburg in 1894 and moved to Weimar in 1896; his sister moved into the Villa Silberblick in 1897 to care for him; “Friedrich Nietzsche died in the house on 25 August 1900.” https://www.klassik-stiftung.de/en/nietzsche-archiv/
3. Stiftung Nietzsche-Haus in Sils Maria. “The first summer: 1881.” A rented room in the Durisch family's house for seven summers; after an unsuccessful stay taking the waters at Recoaro he went to the Engadine “at the beginning of July 1881,” hoping the dry, sunny climate would relieve “his migraine-like headaches which were often accompanied by vomiting”; a strict daily schedule with “daily 5-7 hours of exercise” and notebooks; the idea of eternal recurrence. https://nietzschehaus.ch/friedrich-nietzsche-in-sils-maria-en/the-first-summer-1881/
4. Nietzsche F. *Ecce Homo*, translated by Anthony M. Ludovici (1911), Project Gutenberg eBook #52190. “Why I Am So Wise,” section 1: “My father died in his six-and-thirtieth year”; in 1879 “my eyes could distinguish nothing that lay three paces away from me”; resignation at Basel; “my first winter in Genoa”; “a headache which lasted three days, accompanied by violent nausea.” “Thus Spake Zarathustra,” section 1: the eternal recurrence “first conceived in the month of August 1881” near Surlej; the spring of 1881 at Recoaro. https://www.gutenberg.org/ebooks/52190
5. Sax L. “What was the cause of Nietzsche's dementia?” *J Med Biogr* 2003;11(1):47-54 (PMID 12522502). Full text read (author's copy, https://www.leonardsax.com/wp-content/uploads/2015/01/Nietzsche.pdf). Headaches from age nine, often right-sided with gastrointestinal symptoms; sick leave in 1871 and 1876; myopia much worse in the right eye (six dioptres at five), right pupil larger since childhood, near blindness of the right eye in 1878; resignation in 1879 with a small pension; the Turin incident of January 3, 1889 (the horse story apocryphal); Basel and Jena asylums; his mother's care from March 1890; death from pneumonia; the argument against syphilis and for a slowly growing right-sided retro-orbital meningioma. https://pubmed.ncbi.nlm.nih.gov/12522502/
6. André C, Rios AR. “Furious Frederich: Nietzsche's neurosyphilis diagnosis and new hypotheses.” *Arq Neuropsiquiatr* 2015;73(12) (open access). Full text read. Severe myopia and pupil asymmetry from childhood; right eye functionally blind by 30; central chorioretinitis in 1878; headaches from school years, mainly right-sided, with photophobia and nausea or vomiting; retirement in 1879; in the 1880s many medicines and “severe insomnia, treated with chloral hydrate, apparently in high doses”; his father's death at 36 with seizures and progressive deficits and an autopsy showing “softening” of the brain; gonorrhea twice in his twenties; elation and depressive episodes (1882, 1886–7); his mother's care from March 1890; strokes and left hemiparesis by 1899; no autopsy; the alternative hypotheses and the conclusion that “an atypical GPI may still nowadays be accepted as the most probable diagnosis.” https://www.scielo.br/j/anp/a/hKjVTWVT6XCm64MBFM4vLjx/?lang=en
7. Hemelsoet D, Hemelsoet K, Devreese D. “The neurological illness of Friedrich Nietzsche.” *Acta Neurol Belg* 2008;108(1):9-16 (PMID 18575181). Abstract only: migraine without aura from childhood; his father “died from stroke at 36”; CADASIL proposed. https://pubmed.ncbi.nlm.nih.gov/18575181/
8. Orth M, Trimble MR. “Friedrich Nietzsche's mental illness—general paralysis of the insane vs. frontotemporal dementia.” *Acta Psychiatr Scand* 2006;114(6):439-444 (PMID 17087793). Abstract only: “It is unclear that Nietzsche ever had syphilis”; frontotemporal dementia proposed. https://pubmed.ncbi.nlm.nih.gov/17087793/
9. Danesh-Meyer HV, Young J. “Friederich Nietzsche and the seduction of Occam's razor.” *J Clin Neurosci* 2010;17(8):966-969 (PMID 20542432). Abstract only: neither general paresis nor a frontal meningioma is convincing; migraine; blindness of the right eye from high progressive myopia with retinal degeneration; anisocoria from a unilateral tonic pupil. https://pubmed.ncbi.nlm.nih.gov/20542432/
10. Owen CM, Schaller C, Binder DK. “The madness of Dionysus: a neurosurgical perspective on Friedrich Nietzsche.” *Neurosurgery* 2007;61(3):626-632 (PMID 17881977). Abstract only: severe, generally right-sided headaches from his late 20s; a medial sphenoid wing meningioma proposed. https://pubmed.ncbi.nlm.nih.gov/17881977/
11. HISTMED Master Roster v3. Internal project source; not treated as independent corroboration.

## Clinical guidance

1. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. *Cephalalgia* 2018;38(1):1-211 (PMID 29368949): chronic migraine and medication overuse headache. https://pubmed.ncbi.nlm.nih.gov/29368949/
2. Ailani J, Burch RC, et al. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. *Headache* 2021;61(7):1021-1039 (PMID 34160823). https://pubmed.ncbi.nlm.nih.gov/34160823/
3. Charles AC, Digre KB, et al. Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. *Headache* 2024;64(4):333-341 (PMID 38466028). https://pubmed.ncbi.nlm.nih.gov/38466028/
4. Diener HC, Antonaci F, et al. European Academy of Neurology guideline on the management of medication-overuse headache. *Eur J Neurol* 2020;27(7):1102-1116 (PMID 32430926): education, withdrawal with preventive treatment, abrupt withdrawal of simple analgesics and triptans, and “slow tapering” of barbiturates. https://pubmed.ncbi.nlm.nih.gov/32430926/
5. Sacco S, et al. European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update. *J Headache Pain* 2022;23(1):67 (PMID 35690723). https://pubmed.ncbi.nlm.nih.gov/35690723/
6. Bendtsen L, Sacco S, et al. Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation. *J Headache Pain* 2018;19(1):91 (PMID 30259200). https://pubmed.ncbi.nlm.nih.gov/30259200/
7. Loder E, et al. Choosing wisely in headache medicine. *Headache* 2013;53(10):1651-1659 (PMID 24266337): imaging only when the pattern or examination calls for it. https://pubmed.ncbi.nlm.nih.gov/24266337/
8. Workowski KA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. *MMWR Recomm Rep* 2021;70(4):1-187 (PMID 34292926): syphilis serology. https://pubmed.ncbi.nlm.nih.gov/34292926/
9. American Academy of Ophthalmology. Refractive Errors Preferred Practice Pattern. *Ophthalmology* 2023;130(3):P1-P60 (PMID 36543603). https://pubmed.ncbi.nlm.nih.gov/36543603/
10. American Academy of Ophthalmology. Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration Preferred Practice Pattern. *Ophthalmology* 2025;132(4):P163-P196 (PMID 39918519). https://pubmed.ncbi.nlm.nih.gov/39918519/
11. American Academy of Ophthalmology. Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern. *Ophthalmology* 2026;133(4):P202-P236 (PMID 41670577). https://pubmed.ncbi.nlm.nih.gov/41670577/
12. Edinger JD, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. *J Clin Sleep Med* 2021;17(2):255-262 (PMID 33164742). https://pubmed.ncbi.nlm.nih.gov/33164742/
13. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), depression, bipolar, and mood disorders monograph: PHQ-9 screening and reassessment. https://patrickrutledge.github.io/topthirty/
14. U.S. Preventive Services Task Force: depression (2023), statins (2022), prediabetes and type 2 diabetes (2021), HIV (2019), hepatitis C (2020), unhealthy alcohol use (2018), and the A and B recommendations. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
15. Centers for Disease Control and Prevention. Screening and Testing for Hepatitis B Virus Infection, 2023 (PMID 36893044), and the Adult Immunization Schedule by Age. https://pubmed.ncbi.nlm.nih.gov/36893044/; https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html
16. Medicare Preventive Services reference (Aether Forge, 2026). https://patrickrutledge.github.io/preventative_services/

## Editorial resolutions

- **Sources.** The case relies on the Stanford Encyclopedia of Philosophy, the Klassik Stiftung Weimar (which holds the Nietzsche-Archiv and, in the Goethe- und Schiller-Archiv, his estate), the Nietzsche-Haus in Sils Maria, his own *Ecce Homo* in a public-domain translation, and the full texts of Sax (2003) and André and Rios (2015). For Hemelsoet et al. (2008), Orth and Trimble (2006), Danesh-Meyer and Young (2010) and Owen et al. (2007) only the PubMed abstracts were read. Britannica could not be fetched (access refused) and is not cited. His letters in the digital critical edition (nietzschesource.org) could not be read without a browser and are not cited; no letter is quoted except through the sources above.
- **Index age and dates.** The index visit on July 7, 2026 maps to July 7, 1881, a few days after he reached Sils Maria “at the beginning of July 1881” for his first summer there; he was 36. The synthetic date of birth is October 15, 1989 (shift 145 years). The visits on July 21, August 4, August 18, September 1 and September 15, 2026 map to the same days of 1881. The Nietzsche-Haus places him in Sils Maria for that summer and his own account places the eternal-recurrence idea there in August 1881; the exact day he left in the autumn was not verified, so the last visit was kept in mid-September and the three-month review is left as a goal date without a visit. Past medical history includes only events up to 1879; historical claims about later events are linked to later timeline events and are left out of the intake documents.
- **Father (CLM-0002, family history).** His own account says his father died “in his six-and-thirtieth year” (at 35); André and Rios and Hemelsoet et al. give 36. The case records “35 or 36.” The autopsy finding of “softening” of the brain is recorded as written, and the cause is “not established”; no modern diagnosis is given to his father. Statements in one source about his father's own headaches and mood are left out, as health facts about a relative that the episode does not need. His fear of a similar illness is a synthetic concern of the patient; no statement or decision is attributed to any relative.
- **Disputed final illness (CLM-0013, R, disputed).** His physicians diagnosed general paresis of the insane, the traditional neurosyphilis account. Sax (2003) argued for a right-sided retro-orbital meningioma, Owen et al. (2007) for a sphenoid wing meningioma, Orth and Trimble (2006) for frontotemporal dementia, and Hemelsoet et al. (2008) for CADASIL; Danesh-Meyer and Young (2010) found neither general paresis nor a meningioma convincing; André and Rios (2015) judge the question open while regarding an atypical general paresis as the most probable. No cause of the dementia is treated as established, and none is diagnosed in the modern episode. The roster's “probable neurosyphilis” and “probable syphilitic dementia” are therefore recorded only as the disputed historical diagnosis.
- **Migraine (CLM-0014, R, disputed).** Migraine is a retrospective interpretation; the modern chronic migraine diagnosis is synthetic and rests on a synthetic diary.
- **Synthetic MRI and syphilis serology.** The modern MRI with and without contrast is normal apart from elongated globes and a right posterior staphyloma of high myopia: no structural lesion is invented, and the normal result is not a claim about the historical meningioma debate. Imaging is justified in the modern episode by a strongly one-sided pattern, a rising frequency, long-standing unequal pupils and a poor eye. Syphilis serology (treponemal immunoassay with an index of 0.12 and RPR, both nonreactive) is ordered because of past gonorrhea, the unequal pupils and the poor vision; the result is nonreactive because the modern episode diagnoses migraine and medication overuse, and a positive result would read as a claim about the historical dispute. The RPR is narrative, since the record's observations must be numeric. Serology was ordered at intake and drawn on the morning of the consultation with the MRI, so its result first appears at the consultation.
- **Gonorrhea (CLM-0010, D, probable, sensitive).** André and Rios report that he admitted to gonorrhea twice in his twenties. It is recorded plainly in past medical history because it bears on the historical debate and on the modern serology decision; it is not a claim that he had syphilis.
- **Sedatives (CLM-0009, D, probable, sensitive).** His use of chloral hydrate “apparently in high doses” and many other medicines in the 1880s anchors the modern sedative-analgesic overuse. Chloral hydrate is not used in modern practice; the synthetic overused medicine is a butalbital, acetaminophen and caffeine combination (a barbiturate with an analgesic), which shows both medication overuse headache and the need to taper a barbiturate. It is not a claim about his real medicines.
- **Eyes (CLM-0003, D; CLM-0015, R).** His severe myopia, worse in the right eye, the right pupil larger since childhood, and near blindness of the right eye are documented. The modern pathologic myopia of the right eye with macular atrophy, the refraction (about -13.50 and -6.25 dioptres), the vision (20/100 and 20/20), the pressures and the contact lenses are synthetic, chosen to fit the documented history and the reading of Danesh-Meyer and Young. The unequal pupils are recorded as long-standing and both reactive; no tonic pupil or other pupil diagnosis is made.
- **Sister and mother.** His sister's founding of the Nietzsche Archive and her editing of *The Will to Power*, criticized in the Stanford Encyclopedia, are recorded as documented history (CLM-0017) and linked to a timeline event after his mother's death; his mother's and sister's care in his last years is history (CLM-0012). Neither has any role, statement or decision in the modern episode, and no health fact about either is recorded.
- **Mood.** The depressive episodes in his letters after 1880 (CLM-0016, R, possible, sensitive) are after the index date and are not used as a diagnosis. The modern PHQ-9 is 7 at intake and 4 at ten weeks, with item 9 scored 0, and no F-code problem is recorded, so no safety assessment is required; direct questions about hopelessness and self-harm are documented at each focused visit.
- **Name.** “Friedrich Wilhelm Nietzsche,” his full name, is the alias; no other record uses it. No other figure with a record in the dataset is named.
- **Roster leads.** The roster's migraines, dementia, mental collapse at 44 and severe vision problems are all documented and used as history; “probable neurosyphilis” is recorded only as disputed (see above).
- **Instruments.** The MIDAS is recorded as its five PhenX LOINC items (unit days), with the total in the notes; the HIT-6, the SNNOOP10 screen, the diary, sleep hours and the RPR are narrative. Intraocular pressures are imaging-category observations.
- **Clinical judgment calls.** (1) MRI with and without contrast rather than no imaging, for the reasons above; normal result. (2) Syphilis serology nonreactive; no lumbar puncture. (3) No medicine change at intake beyond education and a cap on the tablets, so that the diary records his baseline before the consultation. (4) A three-week scheduled taper of the butalbital combination, because barbiturates are tapered (EAN 2020), with prevention started the same day (EHF 2022); ibuprofen stopped at once. (5) Galcanezumab over topiramate (cognitive effects and the rare acute myopia with angle-closure glaucoma, a poor fit for a writer with high myopia), over erenumab (constipation), and over onabotulinumtoxinA as first choice (injections every 12 weeks at a center while he travels), with onabotulinumtoxinA as the next option. (6) Naproxen with metoclopramide during the taper and sumatriptan added after it, with limits of two days a week and eight triptan days a month. (7) Contact lenses for an anisometropia of about seven dioptres. (8) CBT-I without sedative sleeping tablets. (9) Medication overuse headache resolved at eight weeks; chronic migraine left active, with efficacy to be judged formally at three months.
- **Preventive visit.** A periodic adult preventive visit at 36 (CPT 99395 with 99497 in plain text). Judgment calls: no lipid testing before 40 without risk factors; no diabetes screening at a BMI of 22.1; one-time HIV, hepatitis C and hepatitis B screening (negative, reported at eight weeks); syphilis up to date; Tdap, the first hepatitis B vaccine dose and the influenza vaccine given; COVID-19 vaccine declined as an individual decision; advance care planning records an unnamed agent, a friend with whom he corresponds.
- **Sick visit.** An acute posterior vitreous detachment of the right eye without a retinal break, chosen because it tests the plan: high myopia raises the risk of a retinal tear, flashes and floaters in one eye must be told apart from migraine aura, and the eye needs a same-day dilated examination and a repeat within six weeks (done at the eight-week review). It is not a historical claim.
- **Focused visits.** The three chronic-care follow-ups (two weeks with the consultation, four weeks, eight weeks) are documented as focused visits on ICHD-3, the 2021 AHS consensus and its 2024 position statement, the 2020 EAN guideline on medication-overuse headache, the 2022 EHF CGRP antibody guideline and the 2018 EHF onabotulinumtoxinA guideline, the AHS Choosing Wisely list, the CDC STI guideline, the AAO refractive errors, comprehensive eye evaluation and posterior vitreous detachment Preferred Practice Patterns, the AASM insomnia guideline and the CMID depression monograph. One deviation is recorded instead of an invented result: the nurse phone check planned for the end of the first taper week did not take place; no harm resulted (rebound headache only, no withdrawal symptoms, taper completed as written), and the corrective action is to book phone checks at the visit that starts any taper. Synthetic findings introduced: rebound headache in the first ten days of the taper, mild redness at the first injection site, and the posterior vitreous detachment.
- **Consultation.** The headache medicine referral and the consultation by Ingeborg Achterberg-Sato, MD (a fictional consultant), on the day of the two-week visit, are **S**. The consultant answers the five referral questions in line with what the record shows afterwards: chronic migraine and medication overuse headache by ICHD-3 criteria; no secondary cause on MRI, serology or the eye examination, and no genetic testing for his father's unexplained illness; the three-week taper with naproxen and metoclopramide and sumatriptan after it; galcanezumab with onabotulinumtoxinA as the next option; and a written plan before he leaves for the winter. The phone check the consultant recommended is the recorded deviation.
